Key Takeaways
- Remicade (infliximab) is a biologic medication that blocks tumor necrosis factor (TNF), a protein that drives inflammation in several autoimmune conditions.
- Patients are often referred for Remicade infusion therapy when oral medications have not adequately controlled symptoms of conditions such as rheumatoid arthritis, Crohn's disease, or ulcerative colitis.
- The goal of Remicade infusion therapy is to reduce inflammation, ease symptoms, and in some cases slow or prevent further damage to joints or the digestive tract.
- Dosing and scheduling are personalized based on the condition being treated, the patient's weight, and how well the patient responds to earlier infusions.
- Suite Life administers Remicade and other infusion therapies at locations across Massachusetts and Rhode Island, with a clinical team that coordinates directly with each patient's referring provider. Patients with a referral for Remicade can request an appointment to get started.
How Remicade Works in the Body
Remicade is the brand name for infliximab, a type of biologic medication known as a TNF blocker. TNF, short for tumor necrosis factor, is a protein the immune system produces that plays a central role in inflammation. In autoimmune and inflammatory conditions, the body produces too much TNF, which leads to ongoing inflammation in the joints, digestive tract, or skin, depending on the condition.
Remicade works by binding to TNF and blocking its activity. This helps calm the overactive immune response that causes symptoms such as joint swelling, digestive pain, or skin flare-ups. According to Mayo Clinic, infliximab is a monoclonal antibody that works to modify the immune system's response, and it is generally reserved for patients who have not had success with other treatments.
Why Some Patients Receive Remicade as an Infusion Rather Than a Pill
Not every medication can be taken as a pill. Infliximab is a large protein molecule that would be broken down by the digestive system before it could reach the bloodstream in an effective form. Delivering it through an IV infusion allows the full dose to enter the bloodstream directly, where it can begin working on inflammation right away.
For patients who have already tried oral disease-modifying medications or other treatments without enough relief, infusion therapy offers a different mechanism and delivery method that some prescribing providers consider when a treatment plan needs to change.
What Conditions Remicade Is Used to Treat
Remicade holds FDA approval for several inflammatory and autoimmune conditions. According to its FDA approval history, Remicade was first approved for Crohn's disease in 1998 and has since been approved for additional conditions, including rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, ulcerative colitis, and plaque psoriasis.
At Suite Life, Remicade is most commonly administered for:
- Rheumatoid arthritis, usually in combination with methotrexate
- Psoriatic arthritis
- Ankylosing spondylitis
- Crohn's disease
- Ulcerative colitis
The dosing schedule differs by condition, as shown below.
| Condition | Typical Starting Schedule | Typical Maintenance Schedule |
|---|---|---|
| Rheumatoid arthritis | Doses at weeks 0, 2, and 6 | Every 8 weeks |
| Ankylosing spondylitis | Doses at weeks 0, 2, and 6 | Every 6 weeks |
| Psoriatic arthritis | Doses at weeks 0, 2, and 6 | Every 8 weeks |
| Crohn's disease | Doses at weeks 0, 2, and 6 | Every 8 weeks |
| Ulcerative colitis | Doses at weeks 0, 2, and 6 | Every 8 weeks |
A prescribing provider may adjust dosing based on how a patient responds to treatment.
What the Treatment Goal Typically Looks Like
For most conditions, the goal of Remicade infusion therapy is to reduce the signs and symptoms of active disease and, in conditions like rheumatoid arthritis and psoriatic arthritis, to help slow the progression of joint damage. For Crohn's disease and ulcerative colitis, the goal often includes reducing symptoms and helping patients reach and maintain remission.
Improvement is not always immediate. Some patients notice a difference after the first one or two doses, while others may need to complete the full induction series, at weeks 0, 2, and 6, before the medication's full effect becomes clear.
How Treatment Plans Are Personalized
Every Remicade treatment plan at Suite Life begins with a referral and a prescription from the patient's rheumatologist, gastroenterologist, or other treating provider. That provider determines the diagnosis, the appropriate dose based on the patient's weight and condition, and the maintenance schedule going forward. Suite Life's clinical team then handles the logistics: scheduling each visit, verifying insurance, and communicating with the referring provider about how the patient is responding.
Patients with questions about a personalized dosing schedule should direct those questions to their prescribing provider, since Suite Life administers the treatment plan the referring provider has already established.
What Patients Can Expect Once Therapy Begins
A typical Remicade infusion takes place over at least two hours, allowing the clinical team to monitor for any reaction during the infusion. Patients receiving care at Suite Life have access to private treatment rooms, comfortable seating, Wi-Fi, and light refreshments during each visit. Visit suitelifehealth.com to see all current locations across Massachusetts and Rhode Island, or explore infusion therapy for rheumatic conditions and infusion therapy for gastrointestinal conditions to see condition-specific details.
Ready to Start Remicade Infusion Therapy?
Remicade is prescribed for a range of inflammatory and autoimmune conditions, and the right treatment plan depends on an individual diagnosis and medical history. Patients who have been referred for Remicade infusion therapy, or who want to ask their provider whether it could be an option, can turn to Suite Life for infusion care across Massachusetts and Rhode Island.
Patients with a referral in hand can request an appointment for Remicade infusion therapy at Suite Life to get scheduled.
Frequently Asked Questions
What is Remicade used for?
Remicade (infliximab) is used to treat several inflammatory and autoimmune conditions, including rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, and ulcerative colitis. It works by blocking TNF, a protein that drives inflammation in these conditions.
How do I find an infusion center near me for Remicade treatment?
Suite Life operates infusion suites across Massachusetts and Rhode Island. After a referring provider prescribes Remicade, Suite Life's team helps identify the most convenient location and schedules the first visit.
How long does a Remicade infusion take?
A Remicade infusion is administered over a period of at least two hours. The clinical team monitors patients throughout the visit and for a short period afterward.
Will I need Remicade infusions indefinitely?
That depends on the condition being treated and how well a patient responds to therapy. Many patients continue on a maintenance schedule for as long as the medication continues to control their symptoms, under their prescribing provider's ongoing supervision.
Do I need a referral to start Remicade infusion therapy?
Yes. Remicade is only administered by prescription. A rheumatologist, gastroenterologist, or other treating provider determines the diagnosis and dosing, then refers the patient to Suite Life for the infusions themselves.
